{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:14:37Z","timestamp":1781640877369,"version":"3.54.5"},"reference-count":13,"publisher":"Elsevier BV","issue":"28","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.vaccine.2017.05.039","type":"journal-article","created":{"date-parts":[[2017,5,22]],"date-time":"2017-05-22T14:33:09Z","timestamp":1495463589000},"page":"3520-3522","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Peritoneal B-1b and B-2 B-cells confer long-term protection from pneumococcal serotype 3 infection after vaccination with Prevnar-13 and are defective in sickle cell disease mice"],"prefix":"10.1016","volume":"35","author":[{"given":"Christina","family":"Cotte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Szczepanek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.05.039_b0005","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1067\/S0022-3476(03)00331-7","article-title":"Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination","volume":"143","author":"Adamkiewicz","year":"2003","journal-title":"J Pediatr"},{"issue":"8","key":"10.1016\/j.vaccine.2017.05.039_b0010","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1002\/pbc.25502","article-title":"13-Valent Pneumococcal Conjugate Vaccine (PCV13) is immunogenic and safe in children 6\u201317years of age with sickle cell disease previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (PPSV23): results of a phase 3 study","volume":"62","author":"De Montalembert","year":"2015","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"10.1016\/j.vaccine.2017.05.039_b0015","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/MPH.0000000000000510","article-title":"Assessing the immunogenic response of a single center\u2019s pneumococcal vaccination protocol in sickle cell disease","volume":"38","author":"Santoro","year":"2016","journal-title":"J Pediatr Hematol Oncol"},{"issue":"5","key":"10.1016\/j.vaccine.2017.05.039_b0020","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.chom.2014.04.005","article-title":"Genomic analyses of pneumococci from children with sickle cell disease expose host-specific bacterial adaptations and deficits in current interventions","volume":"15","author":"Carter","year":"2014","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2017.05.039_b0025","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.ajpath.2012.07.034","article-title":"Splenic morphological changes are accompanied by altered baseline immunity in a mouse model of sickle-cell disease","volume":"181","author":"Szczepanek","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.vaccine.2017.05.039_b0030","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/pr.2013.85","article-title":"Transgenic sickle cell disease mice have high mortality and dysregulated immune responses after vaccination","volume":"74","author":"Szczepanek","year":"2013","journal-title":"Pediatr Res"},{"issue":"2","key":"10.1016\/j.vaccine.2017.05.039_b0035","doi-asserted-by":"crossref","first-page":"e0149261","DOI":"10.1371\/journal.pone.0149261","article-title":"Poor long-term efficacy of Prevnar-13 in sickle cell disease mice is associated with an inability to sustain pneumococcal-specific antibody titers","volume":"11","author":"Szczepanek","year":"2016","journal-title":"PLos One"},{"key":"10.1016\/j.vaccine.2017.05.039_b0040","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.immuni.2005.04.011","article-title":"B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae","volume":"23","author":"Haas","year":"2005","journal-title":"Immunity"},{"issue":"5339","key":"10.1016\/j.vaccine.2017.05.039_b0045","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1126\/science.278.5339.873","article-title":"Knockout-transgenic mouse model of sickle cell disease","volume":"278","author":"Ryan","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2017.05.039_b0050","doi-asserted-by":"crossref","unstructured":"Zuccarino-Catania G, Shlomchik M. Adoptive transfer of memory B cells. Bio Protoc 2015; 5(16) pii: e1563.","DOI":"10.21769\/BioProtoc.1563"},{"issue":"1","key":"10.1016\/j.vaccine.2017.05.039_b0055","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/infdis\/jit442","article-title":"Aging promotes B-1b cell responses to native, but not protein-conjugated, pneumococcal polysaccharides: implications for vaccine protection in older adults","volume":"209","author":"Haas","year":"2014","journal-title":"J Infect Dis"},{"issue":"41","key":"10.1016\/j.vaccine.2017.05.039_b0060","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.1016\/j.vaccine.2013.07.030","article-title":"Pneumococcal polysaccharide vaccination induces polysaccharide-specific B cells in adult peripheral blood expressing CD19+CD20+CD3-CD70-CD27+IgM+CD43+CD5+\/-","volume":"31","author":"Leggat","year":"2013","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2017.05.039_b0065","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jaci.2012.04.040","article-title":"Human CD20+CD43+CD27+CD5- B cells generate antibodies to capsular polysaccharides of Streptococcus pneumoniae","volume":"130","author":"Verbinnen","year":"2012","journal-title":"J Allergy Clin Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17306631?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17306631?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T22:49:45Z","timestamp":1569365385000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17306631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":13,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0264410X17306631"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.05.039","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peritoneal B-1b and B-2 B-cells confer long-term protection from pneumococcal serotype 3 infection after vaccination with Prevnar-13 and are defective in sickle cell disease mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.05.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}